Sleep More, Stress Less: 90-Day Trial of Neuralli Mood
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Psychological Stress, Sleep Disturbance, Anxiety Symptoms, Depressive Symptoms, Occupational Burnout
In brief
This decentralized, single-arm study evaluates the effects of 90 days of daily Neuralli Mood supplementation on perceived stress, sleep disturbance, mood, anxiety, depressive symptoms, happiness, and occupational burnout in adults experiencing stress or occasional sleep disruption. Participants serve as their own controls, completing validated self-report measures before beginning supplementation and again after the 90-day intervention, with safety and adherence check-ins during the study.
Key facts
- Study ID
- NCT07717385
- Run by
- Efforia, Inc
- People needed
- 100
- Starts
- 2026-06-30
- Expected to finish
- 2027-09-28
- Last updated by the study team
- 2026-07-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age 18 years or older and able to provide informed consent.
- Generally healthy adult experiencing stress, occasional sleep disruption, low mood, anxiety symptoms, or work-related burnout.
- Willing and able to take two capsules of Neuralli Mood daily for 90 days.
- Willing and able to complete electronic baseline, follow-up, adherence, and safety assessments.
- Has reliable access to the internet and an email-enabled device.
You may not qualify if…
- Pregnant or nursing.
- Known allergy or hypersensitivity to Neuralli Mood, probiotics, or any product ingredient.
- Severe or unstable gastrointestinal disease, including a condition for which probiotic use may be inappropriate.
- Immunocompromised status or current immunosuppressive therapy.
- Severe or unstable mood disorder, acute psychiatric symptoms, or a current risk of harm to self or others.
- A clinically significant sleep disorder for which participation or changes in symptoms should be managed by a healthcare professional.
- Cognitive impairment or another condition that prevents informed consent or reliable completion of study procedures.
- History of a severe allergic reaction when the investigator determines probiotic use may present an unacceptable risk.
- Use of a medication or presence of a medical condition for which a healthcare professional advises against probiotic supplementation.
- Any other circumstance that, in the investigator's judgment, makes participation inappropriate or unsafe.
Where it is running
- Efforia - Decentralized United States Study — New York, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.